Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ride for Life is a prominent non-profit organization and patient advocacy group dedicated to raising awareness and funding for Amyotrophic Lateral Sclerosis (ALS). Founded in 1997 by Chris Pendergast, the organization is best known for its annual power wheelchair trek across Long Island and Manhattan, which serves as a major fundraising vehicle for neurodegenerative disease research. The funds generated are primarily directed toward clinical trials and patient care initiatives, with a significant portion supporting the Stony Brook ALS Center. While the organization does not develop therapeutics in-house, it plays a crucial role in the ALS ecosystem by providing early-stage funding for research and bridging the gap between patients and the scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ride for Life.